Ophthalmic Drugs Market

• 5.1. Dry Eye
• 5.2. Glaucoma
• 5.3. Infection/Inflammation
• 5.4. Retinal Disorders
  • 5.4.1. Wet AMD
  • 5.4.2. Dry AMD
  • 5.4.3. Diabetic Retinopathy
  • 5.4.4. Others
• 5.5. Allergy
• 5.6. Uveitis
• 5.7. Others

• 6.1. Anti-inflammatory Drugs
  • 6.1.1. NSAID
  • 6.1.2. Steroids
• 6.2. Anti-infective Drugs
  • 6.2.1. Anti-fungal Drugs
  • 6.2.2. Anti-bacterial Drugs
  • 6.2.3. Others
• 6.3. Anti-glaucoma Drugs
  • 6.3.1. Alpha Agonist
  • 6.3.2. Beta Blockers
  • 6.3.3. Prostaglandin Analogs
  • 6.3.4. Combined Medication
  • 6.3.5. Others
• 6.4. Anti-allergy Drugs
• 6.5. Anti-VEGF Agents
• 6.6. Others

• 7.1. Prescription Drugs
• 7.2. OTC Drugs

• 8.1. Hospital Pharmacies
• 8.2. Online Pharmacies
• 8.3. Independent Pharmacies & Drug Stores

• 9.1. North America
• 9.2. Europe
• 9.3. Asia Pacific
• 9.4. Latin America
• 9.5. Middle East and Africa

• 15.1. Aerie Pharmaceuticals, Inc.
• 15.2. ALLERGAN
• 15.3. Valeant Pharmaceuticals International, Inc.
• 15.4. Bayer AG
• 15.5. Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
• 15.6. Novartis AG
• 15.7. Pfizer Inc.
• 15.8. Regeneron Pharmaceuticals, Inc.
• 15.9. Santen Pharmaceutical Co., Ltd.
• 15.10. Shire

Table 01: Product Offering - Major Market Players

Table 02: Global Market Size (US$ Mn) Forecast, by Disease Indication, 2023 to 2033

Table 03: Global Market Size (US$ Mn) Forecast, Market Forecast, by Disease Indication - Retinal Disorder, 2023 to 2033

Table 04: Global Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023 to 2033

Table 05: Global Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drugs, 2023 to 2033

Table 06: Global Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drugs, 2023 to 2033

Table 07: Global Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drugs, 2023 to 2033

Table 08: Global Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 09: Global Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 10: Global Market Size (US$ Mn) Forecast, by Region, 2023 to 2033

Table 11: North America Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

Table 12: North America Market Size (US$ Mn) Forecast, by Disease Indication, 2023 to 2033

Table 13: North America Market Size (US$ Mn) Forecast, Market Forecast, by Disease Indication – Retinal Disorder, 2023 to 2033

Table 14: North America Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023 to 2033

Table 15: North America Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drugs, 2023 to 2033

Table 16: North America Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drugs, 2023 to 2033

Table 17: North America Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drugs, 2023 to 2033

Table 18: North America Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 19: North America Market Size (US$ Mn) Forecast, by Distribution Channels, 2023 to 2033

Table 20: Europe Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2023 to 2033

Table 21: Europe Market Size (US$ Mn) Forecast, by Disease Indication, 2023 to 2033

Table 22: Europe Market Size (US$ Mn) Forecast, Market Forecast, by Disease Indication – Retinal Disorder, 2023 to 2033

Table 23: Europe Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023 to 2033

Table 24: Europe Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drug, 2023 to 2033

Table 25: Europe Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drug, 2023 to 2033

Table 26: Europe Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drug, 2023 to 2033

Table 27: Europe Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 28: Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 29: Asia Pacific Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033

Table 30: Asia Pacific Market Size (US$ Mn) Forecast, by Disease Indication, 2023 to 2033

Table 31: Asia Pacific Market Size (US$ Mn) Forecast, by Disease Indication – Retinal Disorder, 2023 to 2033

Table 32: Asia Pacific Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023 to 2033

Table 33: Asia Pacific Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-inflammatory Drugs, 2023 to 2033

Table 34: Asia Pacific Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-infective Drugs, 2023 to 2033

Table 35: Asia Pacific Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-glaucoma Drugs, 2023 to 2033

Table 36: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 37: Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 38: Latin America Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033

Table 39: Latin America Market Size (US$ Mn) Forecast, by Disease Indication, 2023 to 2033

Table 40: Latin America Market Size (US$ Mn) Forecast, by Disease Indication – Retinal Disorder, 2023 to 2033

Table 41: Latin America Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023 to 2033

Table 42: Latin America Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-inflammatory Drugs, 2023 to 2033

Table 43: Latin America Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-infective Drugs, 2023 to 2033

Table 44: Latin America Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-glaucoma Drugs, 2023 to 2033

Table 45: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 46: Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 47: Middle East & Africa Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2023 to 2033

Table 48: Middle East & Africa Market Size (US$ Mn) Forecast, by Disease Indication, 2023 to 2033

Table 49: Middle East & Africa Market Size (US$ Mn) Forecast, by Disease Indication - Retinal Disorder, 2023 to 2033

Table 50: Middle East & Africa Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023 to 2033

Table 51: Middle East & Africa Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drugs, 2023 to 2033

Table 52: Middle East & Africa Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drugs, 2023 to 2033

Table 53: Middle East & Africa Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drugs, 2023 to 2033

Table 54: Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 55: Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Figure 01: Global Market Size (US$ Mn) Forecast, 2023 to 2033

Figure 02: Global Company Share: Anti-glaucoma Drugs, 2018

Figure 03: Global Causes of Blindness

Figure 04: U.S. - Causes of Blindness

Figure 05: Europe - Causes of Blindness

Figure 06: Japan Causes of Blindness

Figure 07: Global Market Attractiveness, by Disease Indication, 2023 to 2033

Figure 08: Global Market Value Share, by Disease Indication, 2023 and 2033

Figure 09: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Dry Eye, 2023 to 2033

Figure 10: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Glaucoma, 2023 to 2033

Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Infection/Inflammation, 2023 to 2033

Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Retinal Disorders, 2023 to 2033

Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Uveitis, 2023 to 2033

Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Allergy, 2023 to 2033

Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Other Ophthalmic Diseases, 2023 to 2033

Figure 16: Global Market Attractiveness, by Therapeutic Class, 2023 to 2033

Figure 17: Global Market Value Share, by Therapeutic Class, 2023 and 2033

Figure 19: Global Market, by Anti-infective Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 18: Global Market, by Anti-inflammatory Drugs Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 20: Global Market, by Anti-glaucoma Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 21: Global Market, by Anti-VEGF Agents, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 22: Global Market, by Anti-allergy Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 23: Global Market, by Others Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 24: Global Market Value Share, by Product Type, for 2023 and 2033

Figure 25: Global Market Attractiveness, by Product Type, 2023 to 2033

Figure 26: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Prescription Drugs, 2023 to 2033

Figure 27: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by OTC Drugs, 2023 to 2033

Figure 28: Global Market Value Share, by Distribution Channel, for 2023 and 2033

Figure 29: Global Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 30: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Online Pharmacies, 2023 to 2033

Figure 31: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Hospital Pharmacies, 2023 to 2033

Figure 32: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Independent Pharmacies & Drug Stores, 2023 to 2033

Figure 33: Global Market Value Share, by Region, for 2023 and 2033

Figure 34: Global Market Attractiveness, by Region, 2023 to 2033

Figure 35: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 36: North America Market Attractiveness, by Country, 2023 to 2033

Figure 37: North America Market Value Share, by Country, 2023 and 2033

Figure 38: North America Market Attractiveness, By Disease Indication, 2023 to 2033

Figure 39: North America Market Value Share, by Disease Indication, 2023 and 2033

Figure 40: North America Market Value Share, by Therapeutic Class, 2023 and 2033

Figure 41: North America Market Attractiveness, by Therapeutic Class, 2023 to 2033

Figure 42: North America Market Value Share Analysis, by Product Type, 2023 and 2033

Figure 43: North America Market Attractiveness, by Product Type, 2023 to 2033

Figure 44: North America Market Value Share, by Distribution Channels, 2023 and 2033

Figure 45: North America Market Attractiveness, by Distribution Channels, 2023 to 2033

Figure 46: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 47: Europe Market Attractiveness, by Country/Sub-Region, 2023 to 2033

Figure 48: Europe Market Value Share, by Country/Sub-Region, 2023 and 2033

Figure 49: Europe Market Attractiveness, By Disease Indication, 2015-2025

Figure 50: Europe Market Value Share, by Disease Indication, 2023 and 2033

Figure 51: Europe Market Value Share, by Therapeutic Class, 2023 and 2033

Figure 52: Europe Market Attractiveness, by Therapeutic Class, 2023 to 2033

Figure 53: Europe Market Value Share Analysis, by Product Type, 2023 and 2033

Figure 54: Europe Market Attractiveness, by Product Type, 2023 to 2033

Figure 55: Europe Market Value Share, by Distribution Channel, 2023 and 2033

Figure 56: Europe Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 57: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033

Figure 58: Asia Pacific Market Attractiveness, by Country/Sub-region, 2023 to 2033

Figure 59: Asia Pacific Market Value Share, by Country/Sub-region, for 2023 and 2033

Figure 60: Asia Pacific Market Attractiveness, by Disease Indication, 2023 to 2033

Figure 61: Asia Pacific Market Value Share, by Disease Indication, for 2023 and 2033

Figure 62: Asia Pacific Market Attractiveness, by Therapeutic Class, 2023 to 2033

Figure 63: Asia Pacific Market Value Share, by Therapeutic Class, for 2023 and 2033

Figure 64: Asia Pacific Market Value Share Analysis, by Product Type, for 2023 and 2033

Figure 65: Asia Pacific Market Attractiveness, by Product Type, 2023 to 2033

Figure 66: Asia Pacific Market Value Share, by Distribution Channel, for 2023 and 2033

Figure 67: Asia Pacific Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 68: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 69: Latin America Market Attractiveness, by Country/Sub-region, 2023 to 2033

Figure 70: Latin America Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 71: Latin America Market Attractiveness, by Disease Indication, 2023 to 2033

Figure 72: Latin America Market Value Share, by Disease Indication, 2023 and 2033

Figure 73: Latin America Market Attractiveness, by Therapeutic Class, 2023 to 2033

Figure 74: Latin America Market Value Share, by Therapeutic Class, 2023 and 2033

Figure 75: Latin America Market Value Share Analysis, by Product Type, 2023 and 2033

Figure 76: Latin America Market Attractiveness, by Product Type, 2023 to 2033

Figure 77: Latin America Market Value Share, by Distribution Channel, 2023 and 2033

Figure 78: Latin America Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 79: Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 80: Middle East & Africa Market Attractiveness, by Country/Sub-Region, 2023 to 2033

Figure 81: Middle East & Africa Market Value Share, by Country/Sub-Region, 2023 and 2033

Figure 82: Middle East & Africa Market Attractiveness, by Disease Indication, 2023 to 2033

Figure 83: Middle East & Africa Market Value Share, by Disease Indication, 2023 and 2033

Figure 84: Middle East & Africa Market Attractiveness, by Therapeutic Class, 2023 to 2033

Figure 85: Middle East & Africa Market Value Share, by Therapeutic Class, 2023 and 2033

Figure 86: Middle East & Africa Market Value Share Analysis, by Product Type, 2023 and 2033

Figure 87: Middle East & Africa Market Attractiveness, by Product Type, 2023 to 2033

Figure 88: Middle East & Africa Market Value Share, by Distribution Channel, 2023 and 2033

Figure 89: Middle East & Africa Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 90: Global Market Share, by Company, 2018